APA (7th ed.) Citation

LM, S., D, N., FA, H., KH, P., A, P., H, M., . . . J, C. (2025). Combined inhibition of lysine-specific demethylase 1 and kinase signaling as a preclinical treatment strategy in glioblastoma. Neuro-oncology advances, 7(1), vdaf246. https://doi.org/10.1093/noajnl/vdaf246

Chicago Style (17th ed.) Citation

LM, Stitzlein, et al. "Combined Inhibition of Lysine-specific Demethylase 1 and Kinase Signaling as a Preclinical Treatment Strategy in Glioblastoma." Neuro-oncology Advances 7, no. 1 (2025): vdaf246. https://doi.org/10.1093/noajnl/vdaf246.

MLA (9th ed.) Citation

LM, Stitzlein, et al. "Combined Inhibition of Lysine-specific Demethylase 1 and Kinase Signaling as a Preclinical Treatment Strategy in Glioblastoma." Neuro-oncology Advances, vol. 7, no. 1, 2025, p. vdaf246, https://doi.org/10.1093/noajnl/vdaf246.